MANKIND PHARMA
Back to Cashflow Statement
|
MANKIND PHARMA Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-2,953 Cr | ₹10,233 Cr | ₹5.27 Cr | ₹-740 Cr | ₹605 Cr |
What is the latest Cash Flow from Financing Activities ratio of MANKIND PHARMA ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹-2,953 Cr |
| Mar2025 | ₹10,233 Cr |
| Mar2024 | ₹5.27 Cr |
| Mar2023 | ₹-740 Cr |
| Mar2022 | ₹605 Cr |
How is Cash Flow from Financing Activities of MANKIND PHARMA Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-2,953 Cr | Negative | |
| Mar2025 | ₹10,233 Cr | 194,066.22 | |
| Mar2024 | ₹5.27 Cr | Positive | |
| Mar2023 | ₹-740 Cr | Negative | |
| Mar2022 | ₹605 Cr | - | |
Compare Cash Flow from Financing Activities of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹97,253.2 Cr | -2.9% | 2.3% | -3.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,427.0 Cr | -0.2% | -5.1% | 8.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹239,982.0 Cr | -3.8% | -3.2% | 51.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹175,196.0 Cr | -1.7% | -7.7% | 29.9% | Stock Analytics | |
| CIPLA | ₹107,746.0 Cr | 0.6% | -3.8% | -11% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,894.0 Cr | 2.9% | 4.6% | 0.4% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | -2.9% |
2.3% |
-3.3% |
| SENSEX | 0.2% |
-2.8% |
-11.2% |
You may also like the below Video Courses